PHOTOSENSITIZING POTENTIAL OF OFLOXACIN

作者: RICHARD T. SCHEIFE , WENDY R. CRAMER , EDWARD L. DECKER

DOI: 10.1111/J.1365-4362.1993.TB02810.X

关键词: PhototoxicityInternal medicineLomefloxacinEnoxacinFleroxacinMedicinePefloxacinSurgeryCiprofloxacinOfloxacinAmbulatory

摘要: Background. The relative phototoxic risk of ofloxacin, one the newer fluoroquinolones, was compared with that an active control known but low risk, naproxen. Methods. A randomized, controlled, open-label trial used a standardized assay completed at baseline, midway through, and termination 12-day trial. held dermatology research laboratory located large tertiary referral teaching hospital. Thirty healthy volunteers who met inclusion criteria none exclusion were enrolled. Twenty-seven patients Three subjects failed to complete trail. One subject developed exaggerated response Initial photoexposure dropped from study. other two return for follow-up visits. Results. Both ofloxacin agent, naproxen, significantly increased subjects’ tested solar ultraviolet irradiation. There was, however, no significant difference between responses observed versus naproxen any time. Conclusions. Ofloxacin possesses definite potential cause reactions in humans. These study data, concert surveillance suggest hierarchy among fluoroquinolones: fleroxacin ≫ lomefloxacin, pefloxacin ciprofloxacin > enoxacin, norfloxacin, ofloxacin. impact phototoxicity will have on selecting optimum member drug family appears be substantial outpatient ambulatory settings minimal inpatient settings.

参考文章(18)
Tim Jensen, Svend Stenvang Pedersen, Claus Henrik Nielsen, Niels Heiby, Christian Koch, The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis Journal of Antimicrobial Chemotherapy. ,vol. 20, pp. 585- 594 ,(1987) , 10.1093/JAC/20.4.585
R. Stahlmann, Safety profile of the quinolones Journal of Antimicrobial Chemotherapy. ,vol. 26, pp. 31- 44 ,(1990) , 10.1093/JAC/26.SUPPL_D.31
J. Guibert, R. Boutelier, A. Guyot, A clinical trial of pefloxacin in prostatitis Journal of Antimicrobial Chemotherapy. ,vol. 26, pp. 161- 166 ,(1990) , 10.1093/JAC/26.SUPPL_B.161
Guy F. Webster, Kays H. Kaidbey, Albert M. Kligman, PHOTOTOXICITY FROM BENOXAPROFEN: IN VIVO AND IN VITRO STUDIES Photochemistry and Photobiology. ,vol. 36, pp. 59- 64 ,(1982) , 10.1111/J.1751-1097.1982.TB04340.X
J. FERGUSON, B.E. JOHNSON, Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies. British Journal of Dermatology. ,vol. 123, pp. 9- 20 ,(1990) , 10.1111/J.1365-2133.1990.TB01819.X
W R Bowie, V Willetts, P J Jewesson, Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrobial Agents and Chemotherapy. ,vol. 33, pp. 1778- 1782 ,(1989) , 10.1128/AAC.33.10.1778
W. BRUMFITT, J. M. T. HAMILTON-MILLER, W. AL-WALI, Reassessment of cefuroxime axetil for the treatment of recurrent urinary infections. Journal of Antimicrobial Chemotherapy. ,vol. 26, pp. 161- 162 ,(1990) , 10.1093/JAC/26.1.161